Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1293|19|2|102-117

ISSN： 1464-2662

Source： HIV MEDICINE, Vol.19, Iss.2, 2018-02, pp. : 102-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV‐1 DNA dynamics and variations in HIV‐1 DNA protease and reverse transcriptase sequences in multidrug‐resistant patients during successful raltegravir‐based therapy

By  

JOURNAL OF MEDICAL VIROLOGY, Vol. 88, Iss. 12, 2016-12 ,pp. : 2115-2124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of non‐AIDS‐defining events among HIV‐infected patients not yet on antiretroviral therapy

By  

HIV MEDICINE, Vol. 16, Iss. 5, 2015-05 ,pp. : 265-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

By Martinetti Antonia   Miceli Rosalba   Sottotetti Elisa   Di Bartolomeo Maria   de Braud Filippo   Gevorgyan Arpine   Dotti Katia Fiorella   Bajetta Emilio   Campiglio Manuela   Bianchi Francesca   Bregni Giacomo   Pietrantonio Filippo  

Cancers, Vol. 6, Iss. 3, 2014-08 ,pp. : 1753-1768

MDPI

Access to resources Recommend Favorite

Renal impairment in HIV‐infected patients initiating tenofovir‐containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa

By  

TROPICAL MEDICINE & INTERNATIONAL HEALTH, Vol. 20, Iss. 4, 2015-04 ,pp. : 518-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer

By Norian Lyse A.   James Britnie R.   Griffith Thomas S.  

Cancers, Vol. 3, Iss. 1, 2011-02 ,pp. : 603-620

MDPI

Access to resources Recommend Favorite